Cargando…
Combination strategies for pharmacologic treatment of non-alcoholic steatohepatitis
Non-alcoholic steatohepatitis (NASH) is defined as hepatic steatosis, inflammation, and hepatocyte injury with or without fibrosis. It has emerged as the second leading indication for liver transplantation with a rising death rate in the non-transplantable population. While there are many drugs in e...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516677/ https://www.ncbi.nlm.nih.gov/pubmed/36188726 http://dx.doi.org/10.3748/wjg.v28.i35.5129 |